LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 57

Search options

  1. Article ; Online: Editorial commentary: Cystatin C and statins in HIV disease.

    Kalayjian, Robert C

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2014  Volume 59, Issue 8, Page(s) 1157–1159

    MeSH term(s) Female ; Humans ; Male
    Language English
    Publishing date 2014-10-15
    Publishing country United States
    Document type Comment ; Editorial ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciu527
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Bisphosphonates in Perinatally Infected Children and Adolescents With Human Immunodeficiency Virus: Targeting Puberty.

    Kalayjian, Robert C / McComsey, Grace A

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 71, Issue 5, Page(s) 1289–1291

    MeSH term(s) Adolescent ; Alendronate ; Bone Density ; Bone Diseases, Metabolic ; Child ; Diphosphonates/adverse effects ; HIV ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Puberty
    Chemical Substances Diphosphonates ; Alendronate (X1J18R4W8P)
    Language English
    Publishing date 2020-09-01
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciz962
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Kidney Disease in HIV-Infected Persons.

    Kalayjian, Robert C

    Current infectious disease reports

    2011  Volume 14, Issue 1, Page(s) 83–90

    Abstract: Kidney disease is more prevalent among persons living with HIV, and may arise from a combination of comorbidities, co-infections, and medication-associated toxicities. Additional effects of HIV-1 viral replication, immunodeficiency and genetic factors ... ...

    Abstract Kidney disease is more prevalent among persons living with HIV, and may arise from a combination of comorbidities, co-infections, and medication-associated toxicities. Additional effects of HIV-1 viral replication, immunodeficiency and genetic factors also contribute to kidney disease. As is true in the general population, persons of African descent exhibit a disproportionate risk for severe kidney disease. Antiretroviral therapy (ART) modifies the natural history of HIV-associated nephropathy (HIVAN), and renal benefits of ART may not be limited to persons with HIVAN. Robust associations between proteinuria and cardiovascular disease imply that common mechanisms of vascular endothelial dysfunction may contribute to both processes.
    Language English
    Publishing date 2011-12-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2019948-X
    ISSN 1534-3146 ; 1523-3847
    ISSN (online) 1534-3146
    ISSN 1523-3847
    DOI 10.1007/s11908-011-0228-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Renal issues in HIV infection.

    Kalayjian, Robert C

    Current HIV/AIDS reports

    2011  Volume 8, Issue 3, Page(s) 164–171

    Abstract: Kidney disease remains a prominent complication of HIV disease, despite beneficial effects of antiretroviral therapy on the natural history of HIV-associated nephropathy, and on kidney function in general populations of HIV infected patients. Persons of ... ...

    Abstract Kidney disease remains a prominent complication of HIV disease, despite beneficial effects of antiretroviral therapy on the natural history of HIV-associated nephropathy, and on kidney function in general populations of HIV infected patients. Persons of African descent continue to bear a disproportionate burden of severe kidney disease, as is true for the general population. Recently identified genetic variants in the apolipoprotein L1 gene may contribute to this burden. As is also true for the general population, markers of kidney disease, including microalbuminuria, are sensitive predictors of cardiovascular disease and mortality among persons living with HIV. The emerging experience with kidney transplantation also suggests this to be a viable option in selected patients.
    MeSH term(s) Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/adverse effects ; HIV ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Kidney Diseases/chemically induced ; Kidney Diseases/virology
    Chemical Substances Anti-HIV Agents
    Language English
    Publishing date 2011-06-04
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2151206-1
    ISSN 1548-3576 ; 1548-3568
    ISSN (online) 1548-3576
    ISSN 1548-3568
    DOI 10.1007/s11904-011-0080-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The treatment of HIV-associated nephropathy.

    Kalayjian, Robert C

    Advances in chronic kidney disease

    2009  Volume 17, Issue 1, Page(s) 59–71

    Abstract: Antiretroviral therapy (ART) preserves kidney function in patients with human immunodeficiency virus (HIV)-associated nephropathy (HIVAN). Emerging data also document substantial renal benefits of ART in the general HIV-infected population, which is ... ...

    Abstract Antiretroviral therapy (ART) preserves kidney function in patients with human immunodeficiency virus (HIV)-associated nephropathy (HIVAN). Emerging data also document substantial renal benefits of ART in the general HIV-infected population, which is associated in part with suppression of HIV-1 viral replication. The extent to which the response to ART differs in persons with HIVAN compared with those with other HIV-associated kidney disorders is unknown. Beneficial effects of corticosteroids and angiotensin-converting enzyme inhibitors on kidney function also are suggested by retrospective cohort studies and uncontrolled trials of patients with HIVAN. Underexposure to ART or inadequate ART dosing in HIV-infected patients with CKD may curtail the optimal benefits that may be derived from this therapy.
    MeSH term(s) AIDS-Associated Nephropathy/drug therapy ; Adrenal Cortex Hormones/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anti-Retroviral Agents/therapeutic use ; Humans ; Kidney/drug effects
    Chemical Substances Adrenal Cortex Hormones ; Angiotensin-Converting Enzyme Inhibitors ; Anti-Retroviral Agents
    Language English
    Publishing date 2009-12-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ISSN 1548-5609 ; 1548-5595
    ISSN (online) 1548-5609
    ISSN 1548-5595
    DOI 10.1053/j.ackd.2009.08.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy.

    Van Epps, Puja / Kalayjian, Robert C

    Infectious disease clinics of North America

    2017  Volume 31, Issue 4, Page(s) 791–810

    Abstract: Persons living with HIV (PLWH) have accentuated risks for age-associated comorbidities. Compared to the general population, PLWH have a 2-fold higher risk of cardiovascular disease, a 3-fold increased risk of fracture, and a risk of kidney disease that ... ...

    Abstract Persons living with HIV (PLWH) have accentuated risks for age-associated comorbidities. Compared to the general population, PLWH have a 2-fold higher risk of cardiovascular disease, a 3-fold increased risk of fracture, and a risk of kidney disease that is comparable to that in diabetes. Some comorbidities may present at younger ages than among the general population, suggesting the possibility of accelerated aging with HIV infection.
    Language English
    Publishing date 2017-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1077676-x
    ISSN 1557-9824 ; 0891-5520
    ISSN (online) 1557-9824
    ISSN 0891-5520
    DOI 10.1016/j.idc.2017.07.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.

    Luterbach, Courtney L / Qiu, Hongqiang / Hanafin, Patrick O / Sharma, Rajnikant / Piscitelli, Joseph / Lin, Feng-Chang / Ilomaki, Jenni / Cober, Eric / Salata, Robert A / Kalayjian, Robert C / Watkins, Richard R / Doi, Yohei / Kaye, Keith S / Nation, Roger L / Bonomo, Robert A / Landersdorfer, Cornelia B / van Duin, David / Rao, Gauri G

    Antimicrobial agents and chemotherapy

    2022  Volume 66, Issue 10, Page(s) e0059122

    Abstract: Antimicrobial resistance is a global threat. As "proof-of-concept," we employed a system-based approach to identify patient, bacterial, and drug variables contributing to mortality in patients with carbapenem-resistant Klebsiella pneumoniae ( ... ...

    Abstract Antimicrobial resistance is a global threat. As "proof-of-concept," we employed a system-based approach to identify patient, bacterial, and drug variables contributing to mortality in patients with carbapenem-resistant Klebsiella pneumoniae (CR
    MeSH term(s) Humans ; Klebsiella pneumoniae/genetics ; Colistin/pharmacology ; Colistin/therapeutic use ; Prospective Studies ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Ceftazidime/pharmacology ; Ceftazidime/therapeutic use ; Azabicyclo Compounds/pharmacology ; Azabicyclo Compounds/therapeutic use ; Carbapenem-Resistant Enterobacteriaceae/genetics ; Carbapenems/pharmacology ; Carbapenems/therapeutic use ; Drug Combinations ; Sepsis/drug therapy ; Klebsiella Infections/drug therapy ; Klebsiella Infections/microbiology
    Chemical Substances Colistin (Z67X93HJG1) ; Anti-Bacterial Agents ; Ceftazidime (9M416Z9QNR) ; Azabicyclo Compounds ; Carbapenems ; Drug Combinations
    Language English
    Publishing date 2022-09-20
    Publishing country United States
    Document type Multicenter Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 217602-6
    ISSN 1098-6596 ; 0066-4804
    ISSN (online) 1098-6596
    ISSN 0066-4804
    DOI 10.1128/aac.00591-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons.

    Auma, Ann W N / Shive, Carey L / Lange, Alyssa / Damjanovska, Sofi / Kowal, Corinne / Zebrowski, Elizabeth / Pandiyan, Pushpa / Wilson, Brigid / Kalayjian, Robert C / Canaday, David H / Anthony, Donald D

    Frontiers in immunology

    2021  Volume 12, Page(s) 641230

    Abstract: Background: The mechanisms underlying naïve CD4+ lymphopenia during chronic Hepatitis C Virus (HCV ...

    Abstract Background: The mechanisms underlying naïve CD4+ lymphopenia during chronic Hepatitis C Virus (HCV) infection are unclear. Whether direct-acting antiviral (DAA) therapy restores peripheral naïve CD4+ T cell numbers and function is unknown.
    Methods: We enumerated frequencies and counts of peripheral naïve CD4+, CD4+CD31+ and CD4+CD31- T cells by flow cytometry in a cross sectional analysis comparing chronic HCV infected (n=34), DAA-treated(n=29), and age-range matched controls (n=25), as well as in a longitudinal cohort of HCV DAA treated persons (n=16). The cross-sectional cohort was stratified by cirrhosis state. Cell apoptosis/survival (AnnexinV+7AAD+/BCL-2 labeling) and cell cycle entry (Ki67 expression) of CD31+ and CD31- naïve CD4+ T cells was analyzed directly
    Results: In the cross-sectional cohort, naïve CD4+ proportions were lower in chronic HCV infected persons compared to controls and DAA-treated persons, an effect in part attributed to cirrhosis. Age was associated with naïve cell counts and proportions in HCV infected and treated persons as well. Naïve CD4+ cell proportions negatively correlated with plasma levels of soluble CD14 following therapy in DAA-treated persons. Naïve CD4+ cells from HCV infected persons exhibited greater direct
    Conclusions: Activation and apoptosis of peripheral naïve CD4+CD31+ T cells appear to contribute to naïve CD4+ lymphopenia in chronic HCV infection, and this defect is partially reversible with HCV DAA therapy. Age and cirrhosis -associated naïve CD4+ lymphopenia is present both before and after HCV DAA therapy. These findings have implications for restoration of host immune function after DAA therapy.
    MeSH term(s) Antiviral Agents/therapeutic use ; Apoptosis/immunology ; CD4-Positive T-Lymphocytes/immunology ; Cohort Studies ; Cross-Sectional Studies ; Hepatitis C, Chronic/drug therapy ; Hepatitis C, Chronic/immunology ; Humans ; Lymphopenia/immunology ; Lymphopenia/virology ; Platelet Endothelial Cell Adhesion Molecule-1/immunology ; T-Lymphocyte Subsets/immunology
    Chemical Substances Antiviral Agents ; PECAM1 protein, human ; Platelet Endothelial Cell Adhesion Molecule-1
    Language English
    Publishing date 2021-04-12
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.641230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy.

    Auma, Ann W N / Shive, Carey / Damjanovska, Sofi / Kowal, Corinne / Cohen, Daniel E / Bhattacharya, Debika / Alston-Smith, Beverly / Osborne, Melissa / Kalayjian, Robert / Balagopal, Ashwin / Sulkowski, Mark / Wyles, David / Anthony, Donald D

    Open forum infectious diseases

    2021  Volume 8, Issue 4, Page(s) ofab079

    Abstract: ... hepatitis C virus (HCV) infection. We investigated how T-cell and monocyte activation are related over the course ...

    Abstract Background: Immune activation markers associate with morbidity and mortality in HIV and hepatitis C virus (HCV) infection. We investigated how T-cell and monocyte activation are related over the course of HCV direct-acting antiviral (DAA) therapy during HCV/HIV coinfection.
    Methods: Peripheral blood mononuclear cells from AIDS Clinical Trials Group (ACTG) A5329 participants and a single-site separate cohort treated with DAAs were analyzed for central memory (CM)/effector memory (EM) T-cell subsets, monocyte subsets, and cell activation (CD38 and HLA-DR expression) before, during, and after therapy.
    Results: Before therapy, classical and inflammatory monocyte subset HLA-DR expression positively correlated with absolute counts and frequencies of CD38
    Conclusions: During HCV/HIV coinfection, memory T-cell activation is associated with monocyte subset activation, consistent with related underlying mechanisms. Following therapy initiation, memory T-cell, but not monocyte, activation decreased. Residual CD4
    Language English
    Publishing date 2021-02-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2757767-3
    ISSN 2328-8957
    ISSN 2328-8957
    DOI 10.1093/ofid/ofab079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.

    Kalayjian, Robert C / Robertson, Kevin R / Albert, Jeffrey M / Fichtenbaum, Carl J / Brown, Todd T / Taiwo, Babafemi O

    Journal of acquired immune deficiency syndromes (1999)

    2019  Volume 81, Issue 2, Page(s) e49–e54

    Abstract: Objective: To examine associations between plasma cystatin C and neurocognitive impairment (NCI ... Results: Cystatin C was associated with NCI before ART [odds ratio (OR) 3.4 (95% CI: 1.2 to 9.4 ... impairment vs. no impairment]. Cystatin C performed poorly as a diagnostic marker for NCI ...

    Abstract Objective: To examine associations between plasma cystatin C and neurocognitive impairment (NCI) and its performance as a diagnostic marker before and during initial antiretroviral therapy (ART).
    Methods: Multivariable logistic regression and generalized estimating equations examined associations with NCI, determined by neuropsychological measurements, in participants of a 48-week randomized clinical trial of initial ART. Receiver operator characteristic curves examined diagnostic models of NCI.
    Results: Cystatin C was associated with NCI before ART [odds ratio (OR) 3.4 (95% CI: 1.2 to 9.4) for each 2-fold increase in baseline levels] and during 48 weeks of ART, in models that excluded baseline measurements [OR 3.0 (1.2 to 7.8) for each 2-fold increase in time-updated levels]. The strength of association increased with more severe impairment using HIV-associated neurocognitive disorder criteria [OR 2.2 (0.8 to 6.0) with asymptomatic NCI and OR 4.0 (1.5 to 11.0) with mild neurocognitive disorder or HIV-associated dementia vs. no impairment, for each 2-fold increase in time-updated levels] or by global development score [OR 2.6 (1.1 to 6.3) with mild impairment and OR 4.6 (1.1 to 18.9) with moderate or severe impairment vs. no impairment]. Cystatin C performed poorly as a diagnostic marker for NCI, however, with an area under the receiver operator characteristic curve of 0.58 at baseline and 0.54 at week 48.
    Conclusions: Higher plasma cystatin C levels were significantly associated with NCI, but these levels did not seem to be useful as a diagnostic marker for this condition.
    MeSH term(s) AIDS Dementia Complex/drug therapy ; Adult ; Anti-Retroviral Agents/therapeutic use ; Cognitive Dysfunction/complications ; Cystatin C/blood ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; Humans ; Logistic Models ; Male ; Neurocognitive Disorders/complications ; Neurocognitive Disorders/diagnosis ; Neuropsychological Tests ; Odds Ratio ; Plasma ; Viral Load
    Chemical Substances Anti-Retroviral Agents ; CST3 protein, human ; Cystatin C
    Language English
    Publishing date 2019-03-23
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 645053-2
    ISSN 1944-7884 ; 1077-9450 ; 0897-5965 ; 0894-9255 ; 1525-4135
    ISSN (online) 1944-7884 ; 1077-9450
    ISSN 0897-5965 ; 0894-9255 ; 1525-4135
    DOI 10.1097/QAI.0000000000002016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top